Literature DB >> 16856015

Diuretics for Ménière's disease or syndrome.

A S Thirlwall1, S Kundu.   

Abstract

BACKGROUND: Ménière's disease is a disorder characterised by hearing loss, tinnitus and disabling vertigo. Diuretics are used to try and reduce the severity and frequency of episodes but there is little evidence behind this treatment.
OBJECTIVES: To assess the effect of diuretic treatment in patients with Ménière's disease. SEARCH STRATEGY: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 1 2005), MEDLINE (1966 to 2005), EMBASE (1974 to 2005), CINAHL and the metaRegister of Controlled Trials (mRCT) (up to 2005). SELECTION CRITERIA: Randomised controlled trials of diuretic versus placebo in Ménière's patients. DATA COLLECTION AND ANALYSIS: One author identified studies which loosely met the inclusion criteria and full texts were retrieved. Two authors independently applied the inclusion criteria. Seven studies were excluded from the review due to inappropriate study design or absence of randomisation. MAIN
RESULTS: There were no trials of high enough quality to meet the standard set for this review. AUTHORS'
CONCLUSIONS: There is insufficient good evidence of the effect of diuretics on vertigo, hearing loss, tinnitus or aural fullness in clearly defined Ménière's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16856015      PMCID: PMC9007146          DOI: 10.1002/14651858.CD003599.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  18 in total

Review 1.  Betahistine for Menière's disease or syndrome.

Authors:  A L James; M J Burton
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  [Effect of acetazolamide on Menière's disease].

Authors:  G Ralli; D Celestino; M Fabbricatore; S Gabini; L Taverniti
Journal:  Acta Otorhinolaryngol Ital       Date:  1989 Sep-Oct       Impact factor: 2.124

3.  Long-term effect of acetazolamide and chlorthalidone on the hearing loss of Menière's disease.

Authors:  J Corvera; G Corvera
Journal:  Am J Otol       Date:  1989-03

4.  Committee on Hearing and Equilibrium. Report of Subcommittee on Equilibrium and its Measurement. Meniere's disease: criteria for diagnosis and evaluation of therapy for reporting.

Authors: 
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1972 Nov-Dec

5.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

Authors:  K F Schulz; I Chalmers; R J Hayes; D G Altman
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

6.  Treatment of Ménière's disease with isosorbide.

Authors:  M Kitahara; T Takeda; Y Yazawa; H Matsubara; H Kitano
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1982       Impact factor: 1.538

7.  [Long-term therapy of Ménière's disease. Comparison of the effects of betahistine dihydrochloride and hydrochlorothiazide].

Authors:  W Petermann; G Mulch
Journal:  Fortschr Med       Date:  1982-03-11

8.  Epidemiological and clinical characteristics of Menière's disease in Japan.

Authors:  Y Watanabe; K Mizukoshi; H Shojaku; I Watanabe; M Hinoki; M Kitahara
Journal:  Acta Otolaryngol Suppl       Date:  1995

9.  Use of a diuretic (Dyazide) in the treatment of Menière's disease. A double-blind cross-over placebo-controlled study.

Authors:  G W van Deelen; E H Huizing
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1986       Impact factor: 1.538

10.  Natural history vs. surgery for Menière's disease.

Authors:  H Silverstein; E Smouha; R Jones
Journal:  Otolaryngol Head Neck Surg       Date:  1989-01       Impact factor: 3.497

View more
  28 in total

1.  Acute vestibulopathy.

Authors:  Yoon-Hee Cha
Journal:  Neurohospitalist       Date:  2011-01

Review 2.  [Surgical therapy in Menière's disease. Historical development and today's state of the art].

Authors:  G Baier; I Ott
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

3.  MR volumetric assessment of endolymphatic hydrops.

Authors:  R Gürkov; A Berman; O Dietrich; W Flatz; C Jerin; E Krause; D Keeser; B Ertl-Wagner
Journal:  Eur Radiol       Date:  2014-10-16       Impact factor: 5.315

Review 4. 

Authors:  Vincent Wu; Edward A Sykes; Michael M Beyea; Matthew T W Simpson; Jason A Beyea
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275

5.  The evidence base for the evaluation and management of dizziness.

Authors:  Kevin A Kerber; A Mark Fendrick
Journal:  J Eval Clin Pract       Date:  2010-02       Impact factor: 2.431

6.  Treatment of Menière's Disease.

Authors:  Jeffrey D Sharon; Carolina Trevino; Michael C Schubert; John P Carey
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

7.  Menière's Disease and Caloric Stimulation: Some News from an Old Test.

Authors:  Niccolò Cerchiai; Elena Navari; Mario Miccoli; Augusto Pietro Casani
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

8.  Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study.

Authors:  Michael Strupp; Ludwig Kraus; Franz Schautzer; Dan Rujescu
Journal:  J Neurol       Date:  2018-03-12       Impact factor: 4.849

9.  Chiropractic management of a 40-year-old female patient with Ménière disease.

Authors:  Peter C Emary
Journal:  J Chiropr Med       Date:  2010-03

Review 10.  Corticosteroid therapy for hearing and balance disorders.

Authors:  Dennis R Trune; Barbara Canlon
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.